Verona Pharma Plc Overview
Verona Pharma Plc Target Price
Analysts' 12-month price predictions for VRNA.
Share Price
$93.82
Average Target Price
$99.50
6.1% upside
6.1% upside4 analysts in the last 4 months
High: $160 | Low: $75
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-06-23 | Piper Sandler | $160 | 70.5% upside |  |
| 2025-04-21 | Cantor Fitzgerald | $80 |  14.7% downside | |
| 2025-02-28 | Roth Capital | $83 | 11.5% downside | |
| 2025-02-28 | H.C. Wainwright | $75 | 20.1% downside | |
| 2025-01-10 | Roth CapitalBoobalan Pachaiyappan | $68 | 27.5% downside | |
| 2025-01-08 | Wells FargoTiago Fauth | $74 | 21.1% downside | |
| 2024-11-05 | H.C. WainwrightRaghuram Selvaraju | $42 | 55.2% downside | |
| 2024-07-22 | Canaccord GenuityEdward Nash | $37 | 60.6% downside | |
| 2024-06-27 | H.C. WainwrightRaghuram Selvaraju | $36 | 61.6% downside | |
| 2024-05-28 | JefferiesAndrew Tsai | $38 | 59.5% downside | |
| 2024-04-16 | Piper SandlerYasmeen Rahimi | $36 | 61.6% downside | |
| 2022-12-21 | H.C. Wainwright | $32 | 65.9% downside | |
| 2022-12-20 | WedbushAndreas Argyrides | $30 | 68% downside | |
| 2022-12-20 | Truist Financial | $28 | 70.2% downside | |
| 2022-12-20 | BTIG | $26 | 72.3% downside | |
| 2022-08-30 | Canaccord GenuityEdward Nash Nash | $27 | 71.2% downside | |
| 2022-08-30 | WedbushLiana Moussatos Moussatos | $23 | 75.5% downside | |
| 2022-08-30 | H.C. WainwrightRaghuram Selvaraju Selvaraju | $30 | 68% downside | |